Encompass Health Corporation EHC
Set alert
136.36 USD +0.46 +0.34%
As of Nov 2, 11:27 AM ET
134.58 Day range 137.50
92.77 52-week range 137.50
- YTD
- +28.47%
- 1 year
- +19.77%
- Open
- 136.31
- Prev close
- 135.90
- Mkt cap
- 13.40B
- Vol
- 276.89K
- Avg vol
- 1.01M
- EPS
- 6.25
- P/E
- 21.82
- Div yield
- 0.64%
More statistics
- Low
- 134.58
- High
- 137.50
- Forward P/E
- 20.22
- Beta
- 0.60
- Short ratio
- 3.47
- Inst. own
- 100.90%
- Dividend
- 0.84
- Ex-div date
- Jan 3, 2027
- Earnings
- Feb 4, 2027
- 50-d avg
- 122.55
- 200-d avg
- 109.87
- 1y target
- 149.75
5Y chart
Events in this range
- Dec 31, 2021Dividend: 0.28
- Mar 31, 2022Dividend: 0.28
- Jul 1, 2022Split: 1257 for 1000
- Jul 12, 2022Dividend: 0.28
- Sep 30, 2022Dividend: 0.15
- Dec 30, 2022Dividend: 0.15
- Jan 17, 2023Dividend: 0.15
- Mar 31, 2023Dividend: 0.15
- Jun 30, 2023Dividend: 0.15
- Sep 29, 2023Dividend: 0.15
- Dec 29, 2023Dividend: 0.15
- Mar 28, 2024Dividend: 0.15
- Jun 28, 2024Dividend: 0.15
- Jul 1, 2024Dividend: 0.15
- Oct 1, 2024Dividend: 0.17
- Jan 2, 2025Dividend: 0.17
- Apr 1, 2025Dividend: 0.17
- Jul 1, 2025Dividend: 0.17
- Oct 1, 2025Dividend: 0.19
- Oct 29, 2025Earnings: 1.23; estimate 1.19; surprise 3.36%
- Jan 2, 2026Dividend: 0.19
- Feb 5, 2026Earnings: 1.46; estimate 1.29; surprise 13.18%
- Apr 1, 2026Dividend: 0.19
- Apr 30, 2026Earnings: 1.6; estimate 1.51; surprise 5.96%
- Jul 1, 2026Dividend: 0.19
- Aug 5, 2026Earnings: 1.55; estimate 1.48; surprise 4.73%
- Aug 7, 2026Rating: UBS · Buy → Buy
- Aug 10, 2026Rating: TD Cowen · Buy → Buy
- Oct 1, 2026Dividend: 0.21
- Oct 28, 2026Earnings: 1.52; estimate 1.36; surprise 11.76%
- Oct 29, 2026Rating: Barclays · Overweight → Overweight
- Oct 30, 2026Rating: Keybanc · Overweight → Overweight
- Oct 30, 2026Rating: Truist Securities · Buy → Buy
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
Signals (93)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| RSI: Oversold | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| RSI: Overbought | Jun 23, 2025 | 1 year ago |
| RSI: Overbought | Apr 28, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| SMA: Bullish | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Dec 30, 2024 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 9, 2024 | 1 year ago |
| RSI: Overbought | Nov 4, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 21, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 5, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 29, 2024 | 2 years ago |
| RSI: Overbought | Jul 22, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 17, 2024 | 2 years ago |
| RSI: Overbought | May 6, 2024 | 2 years ago |
| RSI: Overbought | Mar 25, 2024 | 2 years ago |
| RSI: Overbought | Mar 4, 2024 | 2 years ago |
| RSI: Overbought | Feb 19, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| SMA: Bearish | Dec 4, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Sep 25, 2023 | 3 years ago |
| SMA: Bullish | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 11, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| SMA: Bearish | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| SMA: Bearish | Feb 27, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 27, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 24, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 5, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 11, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Feb 7, 2022 | 4 years ago |
| SMA: Bearish | Jan 17, 2022 | 4 years ago |
Key statistics
- Market cap
- 13.36B
- Enterprise value
- 16.53B
- Trailing P/E
- 21.75
- Forward P/E
- 20.22
- PEG ratio
- 0.41
- Price / sales
- 2.11
- Price / book
- 5.58
- EPS (TTM)
- 6.25
- Beta
- 0.60
- Dividend yield
- 0.64%
- Payout ratio
- 12.71%
- Profit margin
- 10.17%
- Revenue (TTM)
- 6.34B
- Revenue growth
- 8.90%
- Free cash flow
- 266.90M
- Total cash
- 76.20M
- Total debt
- 2.80B
- Return on equity
- 25.11%
- Shares outstanding
- 98.30M
- Short % of float
- 3.80%
- 50-day average
- 122.55
- 200-day average
- 109.87
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 149.75 +9.8% upside
Now 136.36
- Target (low)
- 140.00
- Target (mean)
- 149.75
- Target (high)
- 157.00
Ratings (0m) 13 13 buy · 0 hold · 0 sell
- Strong buy1
- Buy12
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 1.62.
Financials — quick view
EHC Revenue — quarterly 1.60B
EHC Net income — quarterly 153.90M
EHC EPS — quarterly 1.55
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Dec 30, 2026 | 1.59 | — | — | — |
| Oct 28, 2026 | Sep 30, 2026 | 1.36 | 1.52 | +0.16 | +11.76% |
| Aug 5, 2026 | Jun 30, 2026 | 1.48 | 1.55 | +0.07 | +4.73% |
| Apr 30, 2026 | Mar 31, 2026 | 1.51 | 1.60 | +0.09 | +5.96% |
| Feb 5, 2026 | Dec 31, 2025 | 1.29 | 1.46 | +0.17 | +13.18% |
| Oct 29, 2025 | Sep 30, 2025 | 1.19 | 1.23 | +0.04 | +3.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | TD Cowen | main | Buy | Buy |
| Oct 30, 2026 | Truist Securities | reit | Buy | Buy |
| Oct 30, 2026 | Keybanc | main | Overweight | Overweight |
| Oct 29, 2026 | Barclays | main | Overweight | Overweight |
| Aug 10, 2026 | TD Cowen | main | Buy | Buy |
| Aug 7, 2026 | UBS | main | Buy | Buy |
About Encompass Health Corporation
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- encompasshealth.com
News
- Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
- TD Cowen Maintains Buy on Encompass Health, Raises Price Target to $150
- Truist Securities Reiterates Buy on Encompass Health, Raises Price Target to $156
- Here's Why Encompass Health (EHC) is a Strong Value Stock
- Keybanc Maintains Overweight on Encompass Health, Raises Price Target to $150
- Encompass Health Q3 Earnings Call Highlights
- Encompass Health Corporation (EHC) Q3 2026 Earnings Call Transcript
- Encompass Health Q3 2026 Earnings Call Transcript
- Barclays Maintains Overweight on Encompass Health, Raises Price Target to $151
- Encompass Health (EHC) Reports Q3 Earnings: What Key Metrics Have to Say
Your note
Sign in to keep a note on EHC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHARBONNEAU ELISSA JOY | Officer | Stock Award(Grant) | Feb 18, 2026 | 22,756 |
| COLTHARP DOUGLAS EDWARD | Chief Financial Officer | Sale | Aug 9, 2026 | 241,368 |
| DARBY JOHN PATRICK | General Counsel | Sale | Aug 30, 2026 | 75,041 |
| FAY EDMUND M | Officer and Treasurer | Stock Gift | Mar 8, 2026 | 86,325 |
| HERMAN JOAN E | Director | Stock Award(Grant) | Oct 14, 2026 | 49,724 |
| KATZ LESLYE G | Director | Stock Award(Grant) | Oct 14, 2026 | 49,724 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.63% | 10,484,385 | 1.43B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 5.12% | 5,055,801 | 687.34M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.99% | 4,924,664 | 669.51M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.54% | 4,475,896 | 608.50M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.32% | 3,278,739 | 445.74M | Jun 29, 2026 |
| State Street Corporation | 3.23% | 3,185,798 | 433.11M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 3,514,046 | 477.73M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 3,150,844 | 428.36M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.38% | 2,347,546 | 319.15M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.31% | 2,275,892 | 309.41M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.46% | 1,441,139 | 195.92M | Jun 29, 2026 |
| TR PRICE-Price (T.Rowe) U.S. Large Cap Core Trust | 1.29% | 1,274,147 | 173.22M | Jun 29, 2026 |